28th Jul 2022 7:00 am |
RNS |
PTSD trials with top 10 pharma company & US DoD |
26th Jul 2022 7:00 am |
RNS |
Grant of Options |
22nd Jul 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
22nd Jul 2022 11:00 am |
RNS |
Price Monitoring Extension |
22nd Jul 2022 7:00 am |
RNS |
Director/PDMR Share Purchases |
21st Jul 2022 7:00 am |
RNS |
Trading Update and Notice of Results |
14th Jul 2022 11:06 am |
RNS |
Second Price Monitoring Extn |
14th Jul 2022 11:00 am |
RNS |
Price Monitoring Extension |
30th Jun 2022 5:43 pm |
RNS |
Holding(s) in Company |
8th Jun 2022 3:14 pm |
RNS |
Result of AGM |
16th May 2022 4:35 pm |
RNS |
Posting of Annual Report & Notice of AGM |
12th Apr 2022 7:00 am |
RNS |
Results for the year ended 31 December 2021 |
6th Apr 2022 7:00 am |
RNS |
Senior Management Appointments |
31st Mar 2022 7:00 am |
RNS |
Notice of Results |
29th Mar 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
29th Mar 2022 2:00 pm |
RNS |
Price Monitoring Extension |
28th Mar 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
28th Mar 2022 4:35 pm |
RNS |
Price Monitoring Extension |
28th Mar 2022 7:00 am |
RNS |
£1 million contract for pivotal autoimmune trial |
24th Mar 2022 7:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
4th Feb 2022 12:06 pm |
RNS |
Holding(s) in Company |
2nd Feb 2022 7:00 am |
RNS |
£2.1 million contract |
27th Jan 2022 7:00 am |
RNS |
Trading Update |
10th Jan 2022 7:00 am |
RNS |
New Major Pharma Client for Schizophrenia Trials |
16th Dec 2021 7:00 am |
RNS |
Electronic Clinical Outcomes Assessment Contract |
9th Dec 2021 7:00 am |
RNS |
£1.0m Schizophrenia clinical trial contract |
22nd Nov 2021 11:50 am |
RNS |
Holding(s) in Company |
16th Nov 2021 7:00 am |
RNS |
Grant of Options |
2nd Nov 2021 7:00 am |
RNS |
Directorate Change |
26th Oct 2021 7:00 am |
RNS |
Contract for pivotal schizophrenia clinical trial |
6th Oct 2021 10:06 am |
RNS |
Holding(s) in Company |
21st Sep 2021 7:00 am |
RNS |
Interim Results |
3rd Aug 2021 7:00 am |
RNS |
Trading Update and Notice of Results |
9th Jul 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
9th Jul 2021 4:35 pm |
RNS |
Price Monitoring Extension |
9th Jul 2021 7:00 am |
RNS |
£1 million contract for late phase cancer trial |
1st Jul 2021 7:00 am |
RNS |
Spin-out of Monument Therapeutics |
28th Jun 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
28th Jun 2021 4:36 pm |
RNS |
Price Monitoring Extension |
28th Jun 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |